Coenraad Frederik Slabber

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
BACKGROUND Cancer patients receiving chemotherapy experience thromboembolic complications associated with the use of long-term indwelling central venous catheters (CVCs). This prospective,(More)
5091 Background: A recent phase I study of the combination of CBDCA and Caelyx conducted at The Medical Oncology Centre of Rosebank, Johannesburg has shown that CBDCA at area under the curve (AUC) 5(More)
BACKGROUND A randomized controlled trial tested the hypothesis that aggressive initial therapy using high-dose cyclophosphamide (HiCy) and alpha(2)beta interferon (IFN) may be superior to standard(More)
OBJECTIVE This phase II study assessed the activity and safety of pegylated liposomal doxorubicin (PLD) plus carboplatin in relapsed ovarian cancer (ROC). METHOD Forty women with platinum-sensitive(More)
BACKGROUND Occasional complete responses have been reported in patients with squamous-cell carcinoma of the esophagus treated with carboplatin, and the inferior outcomes seen in early studies might(More)
7349 Background: A recent phase I study of the combination of CBDCA and Caelyx conducted at The Medical Oncology Centre of Rosebank, Johannesburg has shown that CBDCA at area under the curve (AUC) 5(More)